Work

Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein

Year: 2014

Type: article

Source: Leukemia

DOI: 10.1038/leu.2014.21

Authors: S Shukla, E E Chufan, S Singh, A P Skoumbourdis, K Kapoor, M B Boxer, D Y Duveau, C J Thomas, T T Talele, S V Ambudkar

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, St. John's University, National Center for Advancing Translational Sciences

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute for Health and Care Research, National Institutes of Health, National Center for Advancing Translational Sciences

Awards: G6374948078, G9000273969

OpenAlex ID: W1996436910

FWCI: 0.865

Cites: 16

Cited by: 12

Related to: 10